Abstract
Calpain-5/CAPN5 is a calcium-activated, non-lysosomal cysteine (thiol) protease. The substrate repertoire of CAPN5 is not known. Calpains catalyze limited proteolysis of their substrates, generating neo-N-termini that correspond to internal residues of their nascent substrate proteins. To identify such neo-N-termini generated by CAPN5, we employed an N-terminomics approach called TAILS (Terminal amine isotopic labeling of substrates) to quantitatively compare the N-terminal peptides detected in parental and CAPN5-deficient SH-SY5Y neuroblastoma cells. Thirty neo-N-termini corresponding to 29 protein groups and 24 unique proteins were detected to be depleted in the CAPN5−/− cells. A subset of the identified putative substrates was further studied with CAPN5 co-immunoprecipitation, in vitro calcium-induced CAPN5 proteolysis assay, and their cellular fragmentation patterns were compared in parental and CAPN5-deficient SH-SY5Y cells. Here, we provide evidence for CAPN5-mediated proteolysis of the synaptic proteins DLGAP4, IQSEC1 and MPDZ, the neurodegeneration-related EWS, hnRNPU, TFG and UGP2, the DNA replication regulator MCM3, and the neuronal differentiation regulator LMTK1. Our data provide new relevance for neovascular inflammatory vitreoretinopathy (NIV), a progressive eye disease caused by pathogenic mutations in CAPN5. Data are available via ProteomeXchange with identifier PXD064313.
| Original language | English |
|---|---|
| Article number | 6459 |
| Journal | International Journal of Molecular Sciences |
| Volume | 26 |
| Issue number | 13 |
| DOIs | |
| State | Published - Jul 2025 |
Bibliographical note
Publisher Copyright:© 2025 by the authors.
Funding
This research was funded by NIH grant number R01 NS095229 to J.W.G., pilot funding provided by the University of Kentucky Markey Cancer Center’s Cancer Center Support Grant (P30 CA177558) to E.S.Y., and University of Kentucky College of Medicine and Markey Cancer Center startup funds to E.S.Y. The APC was funded by University of Kentucky Markey Cancer Center startup funds to E.S.Y.
| Funders | Funder number |
|---|---|
| University of Kentucky | |
| National Institutes of Health (NIH) | R01 NS095229 |
| University of Kentucky Markey Comprehensive Cancer Center | P30 CA177558 |
Keywords
- CAPN5
- disease
- N-terminomics
- protease
- TAILS
ASJC Scopus subject areas
- Catalysis
- Molecular Biology
- Spectroscopy
- Computer Science Applications
- Physical and Theoretical Chemistry
- Organic Chemistry
- Inorganic Chemistry